Pacemaker and implantable cardioverter‐defibrillator implants were associated with increased risks of mental disorders among young adult recipients in Korea. (Journal of the American Heart Association)
The FDA is hosting a public workshop on chronic hypertension and the need to generate evidence on pediatric treatments.
Over 11,000 bottles of chlorthalidone pills are under Class II recall for not meeting dissolution specifications, the FDA indicated.
The FDA also alerted that Abiomed’s recall involving updated use instructions for Automated Impella Controllers has been classified as Class I, with an expanded explanation for the need for correction.
Greater consumption of sugar-sweetened beverages and fruit juice was linked to a higher risk of hypertension independently of overall diet quality, physical activity, and other factors in a longitudinal cohort study. (Circulation)
A survey identified major gaps in cardio-oncology education during medical school and residency, according to an announcement by the European Society of Cardiology.
Culture may play a role in the effectiveness of bystander help during a heart attack. (Heart)
Research suggested that the benefits of eating nitrate-rich vegetables can be enhanced by chewing sugar-containing gum. (British Journal of Clinical Pharmacology)
For patients requiring aortic valve replacement, the Montreal Heart Institute reported good results with the Ross procedure in a large contemporary series. (Journal of the American College of Cardiology)
Left ventricular diastolic dysfunction is not just an effect, but rather a driver of aortic stenosis, hypothesized one group of researchers (European Heart Journal)
An artificial intelligence program has been developed to comb through NewYork-Presbyterian’s patient records for hidden structural heart disease. (Nature Medicine)
Adjunctive oral nicorandil, an anti-anginal widely available outside the U.S., lowered the incidence of contrast-associated acute kidney injury in percutaneous coronary intervention patients with renal dysfunction, a trial showed. (Circulation: Cardiovascular Interventions)
An investigational gene therapy (AAVrh.10hFXN) had good preliminary results in a 17-person study of Friedreich ataxia cardiomyopathy. (JAMA Cardiology)
Epigenetic clocks, based on DNA methylation, strongly predicted incident worsening of heart failure. (eBioMedicine)
Source link : https://www.medpagetoday.com/cardiology/generalcardiology/121886
Author :
Publish date : 2026-06-23 18:26:00
Copyright for syndicated content belongs to the linked Source.
